PNV 1.16% $2.55 polynovo limited

Ann: Appendix 3B Leon Hoare, page-21

  1. 44 Posts.
    lightbulb Created with Sketch. 7
    I think that the S&N agreement was made under the previous CEO .
    Bone void filler is Possibly one of PNV's best products , but unfortunately when PNV made this agreement we would not have been a comanding position , being a low cap company without a great deal of cash , so it would not have been in our favour .
    By challenging S&Ns inaction on the bone void filler in court , we could meet a fate the same as phosphagenics "BROKE " .
    Better to let it slide and concentrate on our other products and keep full control of them .
    At least PNV is not a one trick pony , with plenty of products to look forward to ,
    I think PNV will become one of australia's premier companies .
 
watchlist Created with Sketch. Add PNV (ASX) to my watchlist
(20min delay)
Last
$2.55
Change
-0.030(1.16%)
Mkt cap ! $1.760B
Open High Low Value Volume
$2.60 $2.61 $2.55 $1.647M 639.8K

Buyers (Bids)

No. Vol. Price($)
1 847 $2.55
 

Sellers (Offers)

Price($) Vol. No.
$2.56 3376 1
View Market Depth
Last trade - 16.10pm 20/08/2024 (20 minute delay) ?
PNV (ASX) Chart
arrow-down-2 Created with Sketch. arrow-down-2 Created with Sketch.